Shares of Meesho, Aequs and Vidya Wires are showing a firm trend in the grey market, with premiums of about 35 percent.
Both companies will finalise their IPO share allotment by December 9, while their shares will be available for trading on the BSE SME effective December 11.
Nephrocare Health Services IPO | The company approached capital markets to raise Rs 871 crore via initial public offering (IPO) comprising fresh issuance of shares worth Rs 353.4 crore.
The proceeds surpassed last year’s high of Rs 1.73 lakh crore, according to data compiled by Bloomberg
As the AMC heads into its IPO, Shah says low fees strengthen — not strain — the business, backed by counter-cyclical products and a rapidly maturing investor base.
India’s second-largest fund house readies three SIF products as it debuts on the bourses; Shah says the new category will complement—not dilute—its MF franchise.
Corona Remedies IPO GMP: Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares with no fresh issue component.
Wakefit IPO GMP: The shares of the company may become attractive to investors with a long-term thesis on consumption growth instead of a short-term listing pop play, an analyst said.
Aequs IPO shares will be listed on both NSE and BSE platforms on December 10, following a whopping 101.63 times subscription in the primary market.
Vidya Wires IPO allotment today: Ahead of listing, the unlisted shares of the company were trading with nearly 8% GMP over the IPO price.
Astron Multigrain share price: Ahead of listing, the unlisted shares of the company were trading flat at the IPO price of Rs 63 per share, with zero GMP, according to data on IPO Watch.
Ravelcare share price: The listing premium is slightly higher than the grey market estimates.
The Rs 28.12 crore issue had a price band of Rs 80-85 per share. The company's market capitalization post listing of shares stood at Rs 125.72-crore.
IPO Allotment Status: Applicants can check their allotment status online on the official websites of BSE and NSE, as well as the official website of the registrar of the respective IPO.
Valuation looks expensive though the company is poised for growth
Meesho IPO shares will be listed on both NSE and BSE platforms on December 10, following a strong subscription of 79 times to its Rs 5,421-crore issue.
Bengaluru-based home & furnishings company Wakefit Innovations, and pharmaceutical firm Corona Remedies will be the first amongst them in the mainboard segment, opening IPOs on December 8 with price band of Rs 185-195 per share and Rs 1,008-1,062 per share, respectively.
AceVector IPO | The public issue is a combination of fresh issuance of shares worth Rs 300 crore, and an offer-for-sale of 6.38 crore equity shares by existing shareholders.
Incorporated in 2015, Shipwaves Online is a unified logistics platform offering seamless multimodal transportation across ocean, land, and air.
Anchor bidding will open on December 11, and the issue will close on December 16. The basis of allotment will be finalised on December 17, while refunds and credit of shares to investor accounts will take place on December 18. The stock is scheduled to list on the exchanges on December 19.
The company’s latest tender offer could value SpaceX at as much as $800 billion, said the people, who asked not to be identified as the information isn’t public.
ICICI Prudential AMC IPO | It is entirely an offer-for-sale of 4.89 crore equity shares (9.9 percent of paid-up equity) by Prudential Corporation Holdings, with no fresh issue component.
The 51:49 joint venture has existed for 26 years with ICICI Bank tying up with Prudential Plc back in 1998
Wakefit Innovations IPO | The company hit Dalal Street with its Rs 1,289-crore initial public offering.
Corona Remedies IPO | The company has finalised allocation of 18.34 lakh shares to anchor investors at the upper price band.